| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.817 | 0.009 | 0.817 | Caspase 9 stimulant | 0.528 0.05 CID_154699899 0.485 0.066 CID_154699604 0.623 0.033 CID_154699574 | ||
| 0.755 | 0.004 | 0.755 | 5 Hydroxytryptamine release inhibitor | |||
| 0.703 | 0.005 | 0.703 | Histamine release inhibitor | 0.211 0.19 CID_154699899 0.203 0.198 CID_154699574 | ||
| 0.685 | 0.009 | 0.685 | Aldehyde oxidase inhibitor | 0.198 0.106 CID_154699899 | ||
| 0.679 | 0.004 | 0.679 | MAO inhibitor | |||
| 0.65 | 0.003 | 0.65 | Aldehyde dehydrogenase inhibitor | 0.119 0.072 CID_154699899 0.139 0.054 CID_154699604 0.189 0.031 CID_154699574 | ||
| 0.639 | 0.004 | 0.639 | MAO B inhibitor | |||
| 0.601 | 0.007 | 0.601 | GABA C receptor rho-3 antagonist | |||
| 0.604 | 0.013 | 0.604 | Spasmolytic | 0.425 0.035 CID_154699899 0.213 0.109 CID_154699604 0.274 0.081 CID_154699574 | ||
| 0.592 | 0.003 | 0.592 | 5 Hydroxytryptamine uptake stimulant | 0.198 0.155 CID_154699604 | ||
| 0.597 | 0.008 | 0.597 | Vasodilator, coronary | 0.201 0.181 CID_154699574 | ||
| 0.555 | 0.005 | 0.555 | MAO A inhibitor | |||
| 0.536 | 0.003 | 0.536 | Carbonic anhydrase XV inhibitor | |||
| 0.535 | 0.003 | 0.535 | Carbonic anhydrase III inhibitor | |||
| 0.575 | 0.055 | 0.688 | Apoptosis agonist | 0.653 0.039 CID_154699899 0.619 0.045 CID_154699604 0.688 0.033 CID_154699574 | CID_154699574 | |
| 0.517 | 0.013 | 0.517 | Amyloid beta aggregation inhibitor | |||
| 0.518 | 0.016 | 0.518 | Lipoxygenase inhibitor | |||
| 0.537 | 0.039 | 0.564 | Transcription factor NF kappa B inhibitor | 0.518 0.042 CID_154699899 0.414 0.06 CID_154699604 0.564 0.036 CID_154699574 | CID_154699574 | |
| 0.5 | 0.005 | 0.5 | Acetylcholinesterase inhibitor | |||
| 0.491 | 0.013 | 0.491 | Vasodilator | 0.339 0.036 CID_154699899 0.264 0.062 CID_154699604 0.324 0.041 CID_154699574 | ||
| 0.48 | 0.022 | 0.48 | Antioxidant | 0.435 0.029 CID_154699899 0.302 0.061 CID_154699604 0.429 0.03 CID_154699574 | ||
| 0.498 | 0.041 | 0.498 | 15-Lipoxygenase inhibitor | |||
| 0.462 | 0.007 | 0.462 | Cholinergic | 0.16 0.069 CID_154699574 | ||
| 0.477 | 0.024 | 0.477 | Caspase 3 stimulant | |||
| 0.456 | 0.005 | 0.456 | Protein kinase stimulant | 0.207 0.039 CID_154699899 0.209 0.038 CID_154699604 0.325 0.014 CID_154699574 | ||
| 0.468 | 0.019 | 0.468 | Free radical scavenger | 0.268 0.061 CID_154699899 0.183 0.112 CID_154699604 0.322 0.046 CID_154699574 | ||
| 0.479 | 0.031 | 0.479 | 5 Hydroxytryptamine release stimulant | 0.463 0.034 CID_154699899 0.249 0.09 CID_154699604 0.17 0.153 CID_154699574 | ||
| 0.482 | 0.036 | 0.724 | Cholesterol antagonist | 0.723 0.007 CID_154699899 0.574 0.022 CID_154699604 0.724 0.006 CID_154699574 | CID_154699574 | |
| 0.486 | 0.044 | 0.486 | Prostaglandin dehydrogenase inhibitor | |||
| 0.457 | 0.02 | 0.457 | Hypoglycemic | 0.233 0.087 CID_154699899 0.193 0.119 CID_154699574 | ||
| 0.435 | 0.003 | 0.435 | Photosensitizer | 0.103 0.082 CID_154699574 | ||
| 0.438 | 0.021 | 0.438 | DNA damaging | 0.206 0.111 CID_154699899 0.364 0.037 CID_154699574 | ||
| 0.421 | 0.004 | 0.421 | Carbonic anhydrase XIII inhibitor | |||
| 0.413 | 0.005 | 0.413 | Butyrylcholinesterase inhibitor | |||
| 0.452 | 0.046 | 0.734 | Immunosuppressant | 0.734 0.004 CID_154699899 0.725 0.005 CID_154699604 0.727 0.005 CID_154699574 | CID_154699899 | |
| 0.42 | 0.023 | 0.42 | Superoxide dismutase inhibitor | |||
| 0.391 | 0.005 | 0.391 | Phospholipase A2 inhibitor | 0.196 0.045 CID_154699899 0.203 0.041 CID_154699604 0.276 0.017 CID_154699574 | ||
| 0.429 | 0.048 | 0.429 | Thyroid hormone antagonist | |||
| 0.413 | 0.05 | 0.413 | Thyroid hormone beta antagonist | |||
| 0.455 | 0.094 | 0.455 | Alpha-glucosidase inhibitor | |||
| 0.368 | 0.011 | 0.368 | Amylase inhibitor | 0.365 0.012 CID_154699899 0.111 0.087 CID_154699604 0.31 0.017 CID_154699574 | ||
| 0.399 | 0.049 | 0.632 | Antithrombotic | 0.632 0.013 CID_154699899 0.429 0.042 CID_154699604 0.601 0.016 CID_154699574 | CID_154699899 | |
| 0.381 | 0.032 | 0.381 | Antiamyloidogenic | |||
| 0.365 | 0.021 | 0.402 | Anesthetic general | 0.402 0.016 CID_154699899 0.2 0.074 CID_154699604 0.377 0.019 CID_154699574 | CID_154699899 | |
| 0.351 | 0.016 | 0.351 | Melanin inhibitor | 0.161 0.068 CID_154699899 0.141 0.095 CID_154699604 0.161 0.069 CID_154699574 | ||
| 0.337 | 0.005 | 0.337 | Carbonic anhydrase VI inhibitor | |||
| 0.344 | 0.014 | 0.344 | Monophenol monooxygenase inhibitor | |||
| 0.373 | 0.046 | 0.73 | Apoptosis antagonist | 0.289 0.093 CID_154699899 0.73 0.004 CID_154699604 0.325 0.07 CID_154699574 | CID_154699604 | |
| 0.306 | 0.007 | 0.306 | Xanthine oxidase inhibitor | |||
| 0.318 | 0.028 | 0.342 | Platelet adhesion inhibitor | 0.249 0.05 CID_154699899 0.342 0.022 CID_154699574 | CID_154699574 | |
| 0.325 | 0.037 | 0.325 | Psychostimulant | |||
| 0.366 | 0.079 | 0.366 | Calpain 2 inhibitor | |||
| 0.326 | 0.042 | 0.461 | Hypolipemic | 0.461 0.016 CID_154699899 0.208 0.089 CID_154699604 0.37 0.031 CID_154699574 | CID_154699899 | |
| 0.414 | 0.131 | 0.725 | Antiinflammatory | 0.706 0.03 CID_154699899 0.581 0.059 CID_154699604 0.725 0.026 CID_154699574 | CID_154699574 | |
| 0.308 | 0.028 | 0.308 | P-glycoprotein inhibitor | 0.262 0.038 CID_154699899 0.153 0.112 CID_154699604 0.281 0.033 CID_154699574 | ||
| 0.292 | 0.012 | 0.292 | Succinate dehydrogenase inhibitor | 0.165 0.088 CID_154699574 | ||
| 0.284 | 0.005 | 0.284 | Calcium antagonist | |||
| 0.306 | 0.027 | 0.306 | Non-steroidal antiinflammatory agent | |||
| 0.283 | 0.01 | 0.283 | Interleukin 4 antagonist | |||
| 0.289 | 0.018 | 0.289 | Insulin sensitizer | |||
| 0.363 | 0.095 | 0.574 | Antibacterial | 0.574 0.024 CID_154699899 0.533 0.032 CID_154699604 0.557 0.027 CID_154699574 | CID_154699899 | |
| 0.293 | 0.026 | 0.293 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.296 | 0.031 | 0.507 | Hepatoprotectant | 0.507 0.007 CID_154699899 0.368 0.017 CID_154699604 0.461 0.009 CID_154699574 | CID_154699899 | |
| 0.273 | 0.008 | 0.273 | GABA C receptor rho-2 antagonist | |||
| 0.263 | 0.002 | 0.263 | Dopamine autoreceptor agonist | |||
| 0.299 | 0.042 | 0.299 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.298 | 0.041 | 0.352 | Nitric oxide antagonist | 0.352 0.031 CID_154699899 0.247 0.052 CID_154699604 0.335 0.034 CID_154699574 | CID_154699899 | |
| 0.325 | 0.072 | 0.607 | Immunostimulant | 0.607 0.016 CID_154699899 0.427 0.042 CID_154699604 0.557 0.022 CID_154699574 | CID_154699899 | |
| 0.332 | 0.081 | 0.443 | Vasodilator, peripheral | 0.443 0.043 CID_154699899 0.245 0.131 CID_154699604 0.425 0.048 CID_154699574 | CID_154699899 | |
| 0.256 | 0.009 | 0.256 | Mediator release inhibitor | |||
| 0.273 | 0.027 | 0.381 | Neurotrophic factor enhancer | 0.322 0.013 CID_154699899 0.302 0.017 CID_154699604 0.381 0.007 CID_154699574 | CID_154699574 | |
| 0.25 | 0.004 | 0.25 | Carbonic anhydrase VB inhibitor | |||
| 0.317 | 0.071 | 0.317 | 12-Lipoxygenase inhibitor | |||
| 0.266 | 0.021 | 0.266 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.312 | 0.069 | 0.366 | Sodium/bile acid cotransporter inhibitor | 0.361 0.033 CID_154699899 0.323 0.059 CID_154699604 0.366 0.03 CID_154699574 | CID_154699574 | |
| 0.303 | 0.06 | 0.303 | Aryl hydrocarbon receptor agonist | |||
| 0.256 | 0.019 | 0.256 | Anesthetic local | |||
| 0.293 | 0.056 | 0.5 | Tumour necrosis factor alpha release inhibitor | 0.5 0.014 CID_154699899 0.243 0.078 CID_154699574 | CID_154699899 | |
| 0.28 | 0.044 | 0.28 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.281 | 0.048 | 0.316 | Gastrin inhibitor | 0.255 0.073 CID_154699899 0.255 0.074 CID_154699604 0.316 0.023 CID_154699574 | CID_154699574 | |
| 0.312 | 0.08 | 0.312 | Calcium channel activator | |||
| 0.287 | 0.057 | 0.595 | Platelet antagonist | 0.507 0.013 CID_154699899 0.382 0.031 CID_154699604 0.595 0.007 CID_154699574 | CID_154699574 | |
| 0.268 | 0.039 | 0.268 | DNA methyltransferase I inhibitor | |||
| 0.264 | 0.042 | 0.394 | RNA-directed DNA polymerase inhibitor | 0.274 0.038 CID_154699899 0.394 0.019 CID_154699604 0.283 0.035 CID_154699574 | CID_154699604 | |
| 0.241 | 0.019 | 0.241 | Cholesterol synthesis inhibitor | 0.222 0.022 CID_154699899 0.13 0.057 CID_154699604 0.232 0.02 CID_154699574 | ||
| 0.234 | 0.014 | 0.234 | Antibacterial (Helicobacter pylori) | |||
| 0.262 | 0.045 | 0.262 | Peroxidase inhibitor | |||
| 0.219 | 0.003 | 0.219 | Potassium channel Kv1.3 blocker | |||
| 0.224 | 0.008 | 0.224 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.234 | 0.018 | 0.234 | 5-Lipoxygenase inhibitor | |||
| 0.219 | 0.004 | 0.219 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.219 | 0.005 | 0.219 | Carbonic anhydrase V inhibitor | |||
| 0.226 | 0.019 | 0.226 | Cystathionine beta-synthase inhibitor | |||
| 0.207 | 0.007 | 0.207 | Macrophage migration inhibitory factor inhibitor | |||
| 0.207 | 0.009 | 0.207 | Creatine kinase inhibitor | |||
| 0.21 | 0.015 | 0.227 | Cyclooxygenase 3 inhibitor | 0.204 0.017 CID_154699899 0.165 0.036 CID_154699604 0.227 0.012 CID_154699574 | CID_154699574 | |
| 0.225 | 0.033 | 0.325 | Interferon gamma antagonist | 0.325 0.017 CID_154699899 0.213 0.037 CID_154699604 0.298 0.02 CID_154699574 | CID_154699899 | |
| 0.212 | 0.022 | 0.214 | Arachidonic acid antagonist | 0.19 0.043 CID_154699899 0.214 0.021 CID_154699604 0.212 0.023 CID_154699574 | CID_154699604 | |
| 0.234 | 0.046 | 0.234 | Dual specificity phosphatase 3 inhibitor | |||
| 0.199 | 0.012 | 0.199 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.221 | 0.034 | 0.221 | Lipid peroxidase inhibitor | 0.155 0.065 CID_154699899 0.136 0.078 CID_154699574 | ||
| 0.214 | 0.028 | 0.214 | ATPase inhibitor | 0.158 0.089 CID_154699899 0.18 0.057 CID_154699574 | ||
| 0.239 | 0.055 | 0.239 | DNA methylase inhibitor | |||
| 0.203 | 0.021 | 0.203 | Farnesoid X receptor antagonist | 0.172 0.034 CID_154699574 | ||
| 0.186 | 0.004 | 0.186 | Oleamide hydrolase inhibitor | |||
| 0.189 | 0.009 | 0.189 | CYP2A6 inhibitor | |||
| 0.183 | 0.006 | 0.183 | Carbonic anhydrase VA inhibitor | |||
| 0.228 | 0.051 | 0.228 | Nitric-oxide synthase stimulant | 0.17 0.153 CID_154699899 | ||
| 0.264 | 0.088 | 0.264 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.255 | 0.079 | 0.255 | Transcription factor STAT3 inhibitor | |||
| 0.188 | 0.012 | 0.188 | Sphingomyelinase inhibitor | 0.098 0.062 CID_154699604 0.084 0.081 CID_154699574 | ||
| 0.184 | 0.01 | 0.184 | Electron transport complex I inhibitor | |||
| 0.207 | 0.034 | 0.235 | Bone formation stimulant | 0.141 0.066 CID_154699899 0.135 0.072 CID_154699604 0.235 0.028 CID_154699574 | CID_154699574 | |
| 0.18 | 0.007 | 0.18 | Interleukin 12 antagonist | |||
| 0.238 | 0.066 | 0.238 | Interleukin antagonist | 0.138 0.128 CID_154699899 | ||
| 0.199 | 0.028 | 0.199 | DNA polymerase I inhibitor | 0.168 0.04 CID_154699899 0.129 0.062 CID_154699604 0.187 0.032 CID_154699574 | ||
| 0.251 | 0.081 | 0.26 | Cardiotonic | 0.26 0.075 CID_154699899 | CID_154699899 | |
| 0.172 | 0.005 | 0.172 | Carbonic anhydrase XIV inhibitor | |||
| 0.204 | 0.041 | 0.345 | Phospholipase C inhibitor | 0.222 0.033 CID_154699899 0.179 0.062 CID_154699604 0.345 0.015 CID_154699574 | CID_154699574 | |
| 0.175 | 0.015 | 0.175 | Alcohol dehydrogenase inhibitor | |||
| 0.177 | 0.018 | 0.177 | GABA C receptor antagonist | |||
| 0.175 | 0.018 | 0.175 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.17 | 0.014 | 0.17 | GABA C receptor rho-1 antagonist | |||
| 0.185 | 0.031 | 0.393 | Alkylator | 0.351 0.01 CID_154699899 0.24 0.018 CID_154699604 0.393 0.008 CID_154699574 | CID_154699574 | |
| 0.19 | 0.037 | 0.19 | Alkaline phosphatase inhibitor | |||
| 0.164 | 0.011 | 0.164 | Aromatase inhibitor | |||
| 0.242 | 0.092 | 0.242 | Transcription factor STAT inhibitor | |||
| 0.161 | 0.011 | 0.161 | Carbonic anhydrase XII inhibitor | |||
| 0.155 | 0.006 | 0.155 | Carbonic anhydrase VII inhibitor | |||
| 0.169 | 0.02 | 0.169 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.192 | 0.046 | 0.25 | Interleukin 6 antagonist | 0.25 0.023 CID_154699899 0.22 0.031 CID_154699574 | CID_154699899 | |
| 0.164 | 0.019 | 0.164 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.159 | 0.014 | 0.159 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.164 | 0.019 | 0.201 | Ca2+-transporting ATPase inhibitor | 0.182 0.006 CID_154699899 0.201 0.003 CID_154699604 0.198 0.004 CID_154699574 | CID_154699604 | |
| 0.177 | 0.035 | 0.177 | Toll-Like receptor 2 antagonist | |||
| 0.19 | 0.051 | 0.19 | Protein-tyrosine phosphatase inhibitor | 0.123 0.11 CID_154699574 | ||
| 0.3 | 0.161 | 0.3 | DNA directed DNA polymerase inhibitor | |||
| 0.151 | 0.013 | 0.151 | Peroxisome proliferator-activated receptor gamma agonist | 0.065 0.054 CID_154699899 | ||
| 0.148 | 0.012 | 0.148 | Ornithine decarboxylase inhibitor | 0.127 0.021 CID_154699899 0.141 0.014 CID_154699604 0.132 0.018 CID_154699574 | ||
| 0.156 | 0.021 | 0.156 | Androgen antagonist | |||
| 0.165 | 0.03 | 0.165 | Interleukin 1b antagonist | |||
| 0.143 | 0.009 | 0.143 | Caspase 7 inhibitor | |||
| 0.138 | 0.004 | 0.138 | Sirtuin 2 inhibitor | |||
| 0.198 | 0.065 | 0.198 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.19 | 0.06 | 0.19 | Dual specificity phosphatase inhibitor | |||
| 0.152 | 0.022 | 0.152 | Estrogen antagonist | |||
| 0.148 | 0.018 | 0.148 | Phosphofructokinase-1 inhibitor | 0.126 0.023 CID_154699899 0.089 0.036 CID_154699604 0.14 0.02 CID_154699574 | ||
| 0.136 | 0.007 | 0.136 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.172 | 0.046 | 0.172 | Interleukin 1 antagonist | |||
| 0.129 | 0.004 | 0.129 | Squalene epoxidase inhibitor | 0.07 0.014 CID_154699899 0.049 0.035 CID_154699604 0.122 0.004 CID_154699574 | ||
| 0.179 | 0.054 | 0.179 | Catenin beta inhibitor | |||
| 0.213 | 0.088 | 0.512 | Angiogenesis stimulant | 0.38 0.025 CID_154699899 0.347 0.033 CID_154699604 0.512 0.011 CID_154699574 | CID_154699574 | |
| 0.206 | 0.083 | 0.206 | ErbB-1 antagonist | |||
| 0.13 | 0.009 | 0.13 | Xanthine dehydrogenase inhibitor | |||
| 0.123 | 0.004 | 0.123 | Cholesterol esterase inhibitor | |||
| 0.149 | 0.032 | 0.149 | TRPA1 agonist | |||
| 0.122 | 0.005 | 0.122 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.132 | 0.016 | 0.132 | Phosphodiesterase 6D inhibitor | |||
| 0.13 | 0.015 | 0.13 | Carbonic anhydrase IX inhibitor | |||
| 0.144 | 0.029 | 0.144 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.157 | 0.043 | 0.157 | Protein-tyrosine phosphatase 1B inhibitor | 0.091 0.088 CID_154699574 | ||
| 0.125 | 0.017 | 0.125 | Estrogen receptor alpha antagonist | |||
| 0.143 | 0.038 | 0.148 | DNA repair enzyme inhibitor | 0.113 0.088 CID_154699899 0.148 0.033 CID_154699574 | CID_154699574 | |
| 0.109 | 0.006 | 0.109 | Exportin-1 inhibitor | |||
| 0.12 | 0.017 | 0.12 | Leukotriene synthesis inhibitor | |||
| 0.107 | 0.004 | 0.107 | Cytokine production stimulant | |||
| 0.177 | 0.074 | 0.177 | Amyloid beta precursor protein antagonist | |||
| 0.122 | 0.021 | 0.122 | Carbonic anhydrase inhibitor | |||
| 0.277 | 0.177 | 0.277 | DNA polymerase beta inhibitor | |||
| 0.119 | 0.019 | 0.119 | CDC25A inhibitor | 0.069 0.059 CID_154699574 | ||
| 0.125 | 0.026 | 0.125 | Toll-Like receptor 3 antagonist | |||
| 0.165 | 0.065 | 0.165 | Diuretic | |||
| 0.126 | 0.026 | 0.126 | Estrogen receptor beta antagonist | |||
| 0.134 | 0.034 | 0.134 | Beta glucuronidase inhibitor | |||
| 0.123 | 0.024 | 0.123 | Chymotrypsin inhibitor | |||
| 0.208 | 0.11 | 0.467 | DNA synthesis inhibitor | 0.4 0.021 CID_154699899 0.305 0.042 CID_154699604 0.467 0.016 CID_154699574 | CID_154699574 | |
| 0.127 | 0.031 | 0.127 | Catalase inhibitor | |||
| 0.222 | 0.126 | 0.222 | Insulysin inhibitor | |||
| 0.112 | 0.017 | 0.112 | Leukotriene antagonist | |||
| 0.128 | 0.033 | 0.128 | Anabolic | 0.114 0.046 CID_154699899 0.126 0.034 CID_154699604 0.123 0.036 CID_154699574 | ||
| 0.117 | 0.022 | 0.125 | ATPase (Vacuolar H+) inhibitor | 0.125 0.017 CID_154699899 0.084 0.068 CID_154699604 0.12 0.02 CID_154699574 | CID_154699899 | |
| 0.11 | 0.015 | 0.11 | Estrogen-related receptor beta agonist | 0.09 0.041 CID_154699574 | ||
| 0.118 | 0.024 | 0.118 | Glutathione S-transferase inhibitor | |||
| 0.114 | 0.02 | 0.114 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.127 | 0.038 | 0.127 | Adenylate kinase inhibitor | |||
| 0.113 | 0.024 | 0.113 | Keratolytic | |||
| 0.126 | 0.039 | 0.126 | Acetylcholine release stimulant | |||
| 0.144 | 0.058 | 0.366 | Alpha-N-acetylglucosaminidase inhibitor | 0.366 0.011 CID_154699899 0.219 0.029 CID_154699604 0.35 0.012 CID_154699574 | CID_154699899 | |
| 0.113 | 0.027 | 0.113 | Bile acid receptor antagonist | 0.107 0.036 CID_154699574 | ||
| 0.124 | 0.04 | 0.231 | Toll-Like receptor 4 antagonist | 0.231 0.004 CID_154699899 0.134 0.031 CID_154699604 0.187 0.008 CID_154699574 | CID_154699899 | |
| 0.095 | 0.011 | 0.095 | Nitric oxide donor | 0.093 0.012 CID_154699899 0.085 0.018 CID_154699574 | ||
| 0.149 | 0.065 | 0.205 | Adenylate cyclase stimulant | 0.185 0.022 CID_154699899 0.179 0.027 CID_154699604 0.205 0.011 CID_154699574 | CID_154699574 | |
| 0.148 | 0.064 | 0.148 | Toll-Like receptor 9 antagonist | |||
| 0.089 | 0.007 | 0.089 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.137 | 0.055 | 0.144 | Vanilloid 1 agonist | 0.144 0.045 CID_154699574 | CID_154699574 | |
| 0.271 | 0.19 | 0.681 | Cyclophilin D inhibitor | 0.681 0.016 CID_154699899 0.524 0.044 CID_154699604 0.63 0.022 CID_154699574 | CID_154699899 | |
| 0.087 | 0.007 | 0.087 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.127 | 0.047 | 0.127 | Chelator | |||
| 0.145 | 0.066 | 0.145 | Cytokine production inhibitor | |||
| 0.085 | 0.006 | 0.085 | Leukotriene C antagonist | |||
| 0.104 | 0.026 | 0.104 | Interferon agonist | 0.074 0.063 CID_154699899 0.094 0.035 CID_154699574 | ||
| 0.092 | 0.016 | 0.092 | Acetyl-CoA transferase inhibitor | |||
| 0.104 | 0.028 | 0.146 | Na+ K+ transporting ATPase inhibitor | 0.138 0.009 CID_154699899 0.128 0.012 CID_154699604 0.146 0.007 CID_154699574 | CID_154699574 | |
| 0.084 | 0.008 | 0.103 | Glucose-6-phosphate isomerase inhibitor | 0.093 0.006 CID_154699899 0.076 0.01 CID_154699604 0.103 0.004 CID_154699574 | CID_154699574 | |
| 0.128 | 0.052 | 0.172 | Microtubule formation inhibitor | 0.16 0.033 CID_154699899 0.109 0.075 CID_154699604 0.172 0.028 CID_154699574 | CID_154699574 | |
| 0.093 | 0.019 | 0.093 | Potassium channel (ATP-sensitive) blocker | |||
| 0.132 | 0.057 | 0.132 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.087 | 0.013 | 0.087 | Leukotriene B4 antagonist | |||
| 0.113 | 0.039 | 0.113 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.092 | 0.018 | 0.092 | Androgen agonist | 0.081 0.024 CID_154699604 | ||
| 0.078 | 0.004 | 0.078 | Delayed rectifier potassium channel blocker | |||
| 0.093 | 0.02 | 0.093 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.111 | 0.038 | 0.111 | ABCA1 expression enhancer | |||
| 0.096 | 0.026 | 0.096 | Amidase inhibitor | |||
| 0.141 | 0.071 | 0.141 | Heat shock protein 70 antagonist | |||
| 0.096 | 0.03 | 0.096 | Lipase inhibitor | |||
| 0.11 | 0.045 | 0.11 | Electrolyte absorption antagonist | |||
| 0.099 | 0.034 | 0.099 | mTOR complex 2 inhibitor | 0.085 0.057 CID_154699574 | ||
| 0.078 | 0.013 | 0.078 | 5 Hydroxytryptamine 1B agonist | |||
| 0.077 | 0.013 | 0.077 | 5-Alpha-reductase inhibitor | |||
| 0.103 | 0.039 | 0.104 | Interleukin 5 antagonist | 0.104 0.037 CID_154699574 | CID_154699574 | |
| 0.094 | 0.03 | 0.269 | Dopamine agonist | 0.133 0.018 CID_154699899 0.145 0.016 CID_154699604 0.269 0.006 CID_154699574 | CID_154699574 | |
| 0.07 | 0.006 | 0.07 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.11 | 0.046 | 0.11 | Prolactin inhibitor | |||
| 0.085 | 0.022 | 0.085 | Aryl hydrocarbon receptor antagonist | |||
| 0.085 | 0.023 | 0.085 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.105 | 0.043 | 0.105 | Thioredoxin inhibitor | 0.087 0.067 CID_154699604 | ||
| 0.145 | 0.085 | 0.145 | CF transmembrane conductance regulator agonist | |||
| 0.066 | 0.006 | 0.066 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.078 | 0.018 | 0.078 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.062 | 0.005 | 0.062 | Retinoid X receptor antagonist | |||
| 0.116 | 0.06 | 0.116 | DNA intercalator | |||
| 0.11 | 0.054 | 0.11 | Gastric antisecretory | 0.092 0.076 CID_154699574 | ||
| 0.153 | 0.097 | 0.153 | Tumour necrosis factor antagonist | |||
| 0.136 | 0.082 | 0.136 | Cyclooxygenase inhibitor | |||
| 0.071 | 0.017 | 0.071 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.06 | 0.006 | 0.06 | Leukotriene C4 antagonist | |||
| 0.073 | 0.022 | 0.073 | Sphingosine kinase inhibitor | |||
| 0.104 | 0.052 | 0.104 | MAP kinase kinase 1 inhibitor | |||
| 0.069 | 0.017 | 0.069 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.127 | 0.076 | 0.127 | Nav1.2 sodium channel blocker | |||
| 0.085 | 0.034 | 0.085 | Phosphodiesterase VI inhibitor | |||
| 0.058 | 0.008 | 0.058 | Peroxisome proliferator-activated receptor delta antagonist | 0.043 0.013 CID_154699899 | ||
| 0.062 | 0.012 | 0.062 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.056 | 0.006 | 0.056 | Melatonin receptor 1A agonist | |||
| 0.189 | 0.14 | 0.189 | Neuropeptide Y2 antagonist | |||
| 0.055 | 0.007 | 0.055 | 5-Alpha-reductase 1 inhibitor | |||
| 0.087 | 0.039 | 0.087 | GABA aminotransferase inhibitor | |||
| 0.123 | 0.076 | 0.123 | Cyclooxygenase 2 inhibitor | |||
| 0.052 | 0.005 | 0.052 | Retinoid X alpha receptor antagonist | |||
| 0.116 | 0.07 | 0.182 | Topoisomerase II inhibitor | 0.143 0.053 CID_154699899 0.111 0.075 CID_154699604 0.182 0.038 CID_154699574 | CID_154699574 | |
| 0.081 | 0.035 | 0.081 | Phosphodiesterase III inhibitor | |||
| 0.18 | 0.135 | 0.18 | Calpain inhibitor | |||
| 0.088 | 0.043 | 0.088 | Thioredoxin reductase inhibitor | |||
| 0.15 | 0.105 | 0.263 | Lipocortins synthesis antagonist | 0.22 0.045 CID_154699899 0.243 0.036 CID_154699604 0.263 0.029 CID_154699574 | CID_154699574 | |
| 0.058 | 0.014 | 0.062 | Neuraminidase (Influenza A) inhibitor | 0.056 0.016 CID_154699899 0.062 0.011 CID_154699574 | CID_154699574 | |
| 0.106 | 0.063 | 0.106 | AMP-activated protein kinase stimulant | |||
| 0.074 | 0.03 | 0.076 | Interferon inducer | 0.06 0.053 CID_154699899 0.076 0.028 CID_154699574 | CID_154699574 | |
| 0.081 | 0.038 | 0.203 | Glycine receptor agonist | 0.119 0.013 CID_154699899 0.149 0.007 CID_154699604 0.203 0.004 CID_154699574 | CID_154699574 | |
| 0.055 | 0.013 | 0.055 | Retinoid X alpha receptor agonist | |||
| 0.063 | 0.022 | 0.063 | Plasminogen activator inhibitor antagonist | |||
| 0.073 | 0.032 | 0.121 | Neuraminidase (influenza) inhibitor | 0.121 0.012 CID_154699899 0.061 0.052 CID_154699604 0.099 0.017 CID_154699574 | CID_154699899 | |
| 0.058 | 0.018 | 0.058 | Sphingosine 1-phosphate receptor agonist | |||
| 0.112 | 0.072 | 0.112 | Proteasome inhibitor | |||
| 0.045 | 0.005 | 0.045 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.067 | 0.027 | 0.156 | Estrogen agonist | 0.156 0.011 CID_154699604 0.043 0.04 CID_154699574 | CID_154699604 | |
| 0.049 | 0.009 | 0.049 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.047 | 0.008 | 0.047 | Leukotriene B4 receptor 1 antagonist | |||
| 0.121 | 0.083 | 0.121 | Toll-Like receptor antagonist | |||
| 0.054 | 0.017 | 0.054 | Progesterone antagonist | |||
| 0.047 | 0.01 | 0.047 | Free fatty acid receptor 1 antagonist | |||
| 0.07 | 0.034 | 0.07 | Beta 3 adrenoreceptor antagonist | |||
| 0.101 | 0.065 | 0.101 | Urease inhibitor | |||
| 0.044 | 0.008 | 0.044 | Estrogen-related receptor beta antagonist | 0.044 0.008 CID_154699574 | ||
| 0.051 | 0.016 | 0.051 | DNA gyrase subunit A inhibitor | |||
| 0.071 | 0.036 | 0.071 | Dopamine D4 antagonist | |||
| 0.069 | 0.034 | 0.099 | Neuraminidase inhibitor | 0.099 0.016 CID_154699899 0.083 0.023 CID_154699574 | CID_154699899 | |
| 0.052 | 0.017 | 0.052 | Retinoid X receptor agonist | |||
| 0.071 | 0.037 | 0.071 | Glutamate (mGluR6) antagonist | |||
| 0.057 | 0.024 | 0.057 | CD45 antagonist | |||
| 0.087 | 0.054 | 0.087 | Myeloperoxidase inhibitor | |||
| 0.076 | 0.044 | 0.076 | Calcium channel L-type blocker | |||
| 0.054 | 0.022 | 0.054 | Carbonic anhydrase IV inhibitor | |||
| 0.078 | 0.046 | 0.078 | Telomerase inhibitor | |||
| 0.104 | 0.072 | 0.19 | Mucolytic | 0.159 0.028 CID_154699899 0.112 0.063 CID_154699604 0.19 0.016 CID_154699574 | CID_154699574 | |
| 0.072 | 0.041 | 0.072 | Acetylcholine M5 receptor agonist | |||
| 0.044 | 0.013 | 0.044 | Melatonin 2 agonist | |||
| 0.158 | 0.128 | 0.158 | Histone acetyltransferase inhibitor | |||
| 0.062 | 0.033 | 0.062 | Ryanodine receptor antagonist | |||
| 0.101 | 0.073 | 0.101 | DOPA decarboxylase inhibitor | |||
| 0.06 | 0.032 | 0.06 | Aldose reductase inhibitor | |||
| 0.138 | 0.11 | 0.138 | Antipruritic | |||
| 0.044 | 0.017 | 0.044 | Nicotinic acid receptor 2 agonist | |||
| 0.07 | 0.043 | 0.07 | Glutamate (mGluR7) antagonist | |||
| 0.047 | 0.021 | 0.047 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.054 | 0.029 | 0.054 | Potassium channel (Inward rectifier) blocker | |||
| 0.094 | 0.069 | 0.167 | UDP-glucose 4-epimerase inhibitor | 0.157 0.027 CID_154699899 0.103 0.058 CID_154699604 0.167 0.024 CID_154699574 | CID_154699574 | |
| 0.037 | 0.013 | 0.037 | Uridine phosphorylase inhibitor | 0.031 0.017 CID_154699574 | ||
| 0.039 | 0.016 | 0.039 | Liver X receptor beta agonist | |||
| 0.042 | 0.018 | 0.042 | Vanilloid 3 antagonist | |||
| 0.067 | 0.043 | 0.067 | Beta adrenoreceptor antagonist | |||
| 0.087 | 0.064 | 0.098 | Triose-phosphate isomerase inhibitor | 0.093 0.056 CID_154699899 0.098 0.049 CID_154699574 | CID_154699574 | |
| 0.088 | 0.066 | 0.089 | Glutamate release inhibitor | 0.089 0.064 CID_154699899 | CID_154699899 | |
| 0.046 | 0.026 | 0.046 | Leukocyte elastase inhibitor | |||
| 0.037 | 0.018 | 0.037 | Melatonin 1 agonist | |||
| 0.062 | 0.043 | 0.062 | Phosphodiesterase 1C inhibitor | |||
| 0.036 | 0.017 | 0.036 | ATP citrate lysase inhibitor | |||
| 0.031 | 0.013 | 0.031 | Estrogen-related receptor gamma antagonist | |||
| 0.055 | 0.037 | 0.055 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.119 | 0.102 | 0.119 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.141 | 0.124 | 0.141 | Neurotensin receptor agonist | |||
| 0.041 | 0.024 | 0.041 | Leukotriene A4 hydrolase inhibitor | |||
| 0.034 | 0.018 | 0.038 | Glutamate (mGluR3) agonist | 0.038 0.012 CID_154699574 | CID_154699574 | |
| 0.048 | 0.032 | 0.061 | Adenosine deaminase inhibitor | 0.061 0.02 CID_154699899 0.057 0.023 CID_154699574 | CID_154699899 | |
| 0.093 | 0.077 | 0.26 | Topoisomerase I inhibitor | 0.213 0.023 CID_154699899 0.17 0.035 CID_154699604 0.26 0.015 CID_154699574 | CID_154699574 | |
| 0.027 | 0.011 | 0.027 | Leukotriene B4 receptor 2 antagonist | |||
| 0.07 | 0.054 | 0.07 | Histone deacetylase SIRT1 stimulant | |||
| 0.07 | 0.054 | 0.07 | Histone deacetylase stimulant | |||
| 0.055 | 0.04 | 0.055 | Alcohol oxidase inhibitor | |||
| 0.045 | 0.03 | 0.045 | Dopamine D2 agonist | |||
| 0.08 | 0.065 | 0.08 | Histamine H2 receptor antagonist | |||
| 0.111 | 0.095 | 0.111 | NADPH oxidase inhibitor | |||
| 0.093 | 0.078 | 0.234 | Expectorant | 0.234 0.015 CID_154699899 0.102 0.066 CID_154699604 0.199 0.02 CID_154699574 | CID_154699899 | |
| 0.076 | 0.06 | 0.393 | Antineoplastic antibiotic | 0.256 0.014 CID_154699899 0.393 0.005 CID_154699604 0.237 0.016 CID_154699574 | CID_154699604 | |
| 0.038 | 0.023 | 0.038 | Nicotinic acid receptor agonist | |||
| 0.166 | 0.152 | 0.292 | Interleukin agonist | 0.289 0.053 CID_154699899 0.211 0.111 CID_154699604 0.292 0.052 CID_154699574 | CID_154699574 | |
| 0.022 | 0.008 | 0.022 | G-protein-coupled receptor 120 agonist | |||
| 0.026 | 0.012 | 0.065 | Prostaglandin F2 alpha agonist | 0.063 0.003 CID_154699899 0.03 0.009 CID_154699604 0.065 0.003 CID_154699574 | CID_154699574 | |
| 0.037 | 0.024 | 0.037 | ATM kinase inhibitor | |||
| 0.087 | 0.075 | 0.087 | Aminopeptidase B inhibitor | |||
| 0.027 | 0.015 | 0.027 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.024 | 0.013 | 0.031 | Isoleucine-tRNA ligase inhibitor | 0.025 0.011 CID_154699899 0.031 0.005 CID_154699574 | CID_154699574 | |
| 0.031 | 0.021 | 0.05 | Prostaglandin agonist | 0.05 0.01 CID_154699899 0.037 0.015 CID_154699574 | CID_154699899 | |
| 0.021 | 0.012 | 0.021 | Retinoid X beta receptor antagonist | |||
| 0.041 | 0.032 | 0.041 | GABA B receptor antagonist | |||
| 0.04 | 0.031 | 0.04 | Sphingosine kinase 1 inhibitor | |||
| 0.084 | 0.075 | 0.084 | Uric acid excretion stimulant | |||
| 0.033 | 0.025 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.067 | 0.058 | 0.067 | Phosphodiesterase 4D inhibitor | |||
| 0.036 | 0.028 | 0.044 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.044 0.016 CID_154699574 | CID_154699574 | |
| 0.07 | 0.062 | 0.076 | Topoisomerase II alpha inhibitor | 0.076 0.056 CID_154699574 | CID_154699574 | |
| 0.032 | 0.024 | 0.032 | Melatonin agonist | |||
| 0.026 | 0.019 | 0.026 | Nicotinic acid receptor 2 antagonist | |||
| 0.021 | 0.016 | 0.021 | Estrone sulfatase inhibitor | |||
| 0.091 | 0.086 | 0.091 | Folate antagonist | |||
| 0.099 | 0.094 | 0.099 | Interleukin 2 antagonist | |||
| 0.058 | 0.053 | 0.058 | Dopamine D1 antagonist | |||
| 0.038 | 0.034 | 0.038 | Liver X receptor alpha agonist | |||
| 0.064 | 0.06 | 0.064 | Dopamine antagonist | |||
| 0.012 | 0.008 | 0.012 | Melatonin 2 antagonist | |||
| 0.013 | 0.01 | 0.013 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.052 | 0.049 | 0.052 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | |||
| 0.029 | 0.026 | 0.029 | Elastase 2B inhibitor | |||
| 0.029 | 0.026 | 0.029 | Elastase 3A inhibitor | |||
| 0.029 | 0.026 | 0.029 | Elastase 3B inhibitor | |||
| 0.02 | 0.017 | 0.036 | Prostaglandin EP2 agonist | 0.036 0.01 CID_154699899 0.022 0.016 CID_154699574 | CID_154699899 | |
| 0.078 | 0.075 | 0.078 | D-Ala-D-Ala ligase inhibitor | |||
| 0.098 | 0.096 | 0.098 | Caspase 3 inhibitor | |||
| 0.05 | 0.048 | 0.05 | Sphingosine kinase 2 inhibitor | |||
| 0.055 | 0.054 | 0.055 | Protease activated receptor antagonist | |||
| 0.055 | 0.053 | 0.055 | Dopamine D2 antagonist | |||
| 0.023 | 0.022 | 0.023 | Leukotriene D4 antagonist | |||
| 0.111 | 0.11 | 0.111 | Nav1.6 sodium channel blocker | |||
| 0.051 | 0.05 | 0.051 | Fatty acid synthase inhibitor | |||
| 0.02 | 0.022 | 0.024 | Prostaglandin E2 agonist | 0.024 0.015 CID_154699899 | CID_154699899 | |
| 0.047 | 0.05 | 0.129 | Alpha-mannosidase inhibitor | 0.109 0.005 CID_154699899 0.078 0.012 CID_154699604 0.129 0.004 CID_154699574 | CID_154699574 | |
| 0.021 | 0.029 | 0.026 | Vanilloid 2 agonist | 0.026 0.016 CID_154699604 | CID_154699604 | |
| 0.138 | 0.146 | 0.536 | Platelet aggregation inhibitor | 0.416 0.017 CID_154699899 0.536 0.007 CID_154699574 | CID_154699574 | |
| 0.114 | 0.122 | 0.326 | Insulin secretagoues | 0.326 0.01 CID_154699899 | CID_154699899 | |
| 0.077 | 0.086 | 0.105 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.105 0.049 CID_154699899 0.091 0.065 CID_154699574 | CID_154699899 | |
| 0.013 | 0.022 | 0.019 | Vitamin D receptor agonist | 0.019 0.008 CID_154699899 0.019 0.008 CID_154699574 | CID_154699574 | |
| 0.104 | 0.114 | 0.574 | Histone deacetylase SIRT1 inhibitor | 0.574 0.003 CID_154699604 | CID_154699604 | |
| 0.047 | 0.06 | 0.065 | Carbamoyl phosphate synthetase inhibitor | 0.054 0.049 CID_154699899 0.065 0.039 CID_154699574 | CID_154699574 | |
| 0.035 | 0.05 | 0.105 | Mannosidase inhibitor | 0.088 0.007 CID_154699899 0.06 0.017 CID_154699604 0.105 0.005 CID_154699574 | CID_154699574 | |
| 0.028 | 0.044 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.038 0.02 CID_154699574 | CID_154699574 | |
| 0.02 | 0.036 | 0.106 | Sodium/glucose cotransporter 2 inhibitor | 0.092 0.003 CID_154699899 0.041 0.008 CID_154699604 0.106 0.003 CID_154699574 | CID_154699574 | |
| 0.023 | 0.04 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.019 CID_154699899 0.032 0.01 CID_154699574 | CID_154699574 | |
| 0.02 | 0.039 | 0.09 | Sodium/glucose cotransporter inhibitor | 0.079 0.004 CID_154699899 0.038 0.008 CID_154699604 0.09 0.003 CID_154699574 | CID_154699574 | |
| 0.105 | 0.127 | 0.121 | Cell wall synthesis inhibitor | 0.121 0.098 CID_154699574 | CID_154699574 | |
| 0.009 | 0.033 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 CID_154699574 | CID_154699574 | |
| 0.004 | 0.03 | 0.018 | Antibiotic Macrolide-like | 0.017 0.008 CID_154699899 0.014 0.009 CID_154699604 0.018 0.007 CID_154699574 | CID_154699574 | |
| 0.064 | 0.09 | 0.157 | Glycine receptor antagonist | 0.111 0.024 CID_154699899 0.157 0.006 CID_154699604 0.127 0.014 CID_154699574 | CID_154699604 | |
| 0.008 | 0.035 | 0.066 | Prostacyclin agonist | 0.065 0.004 CID_154699899 0.034 0.005 CID_154699604 0.066 0.004 CID_154699574 | CID_154699574 | |
| 0.07 | 0.101 | 0.307 | Transcription factor NF kappa B stimulant | 0.292 0.004 CID_154699899 0.251 0.006 CID_154699604 0.307 0.004 CID_154699574 | CID_154699574 | |
| 0.032 | 0.064 | 0.066 | Microtubule stabilization | 0.066 0.009 CID_154699899 0.059 0.016 CID_154699604 0.065 0.009 CID_154699574 | CID_154699899 | |
| 0.07 | 0.102 | 0.118 | NADH dehydrogenase inhibitor | 0.11 0.035 CID_154699899 0.083 0.068 CID_154699604 0.118 0.029 CID_154699574 | CID_154699574 | |
| 0.027 | 0.068 | 0.046 | Guanylate cyclase inhibitor | 0.046 0.025 CID_154699574 | CID_154699574 | |
| 0.032 | 0.073 | 0.087 | Protein 50S ribosomal subunit inhibitor | 0.086 0.017 CID_154699899 0.083 0.018 CID_154699604 0.087 0.017 CID_154699574 | CID_154699574 | |
| 0.01 | 0.051 | 0.019 | Telomerase stimulant | 0.017 0.013 CID_154699899 0.019 0.009 CID_154699604 0.018 0.01 CID_154699574 | CID_154699604 | |
| 0.008 | 0.051 | 0.019 | Thromboxane A2 agonist | 0.019 0.007 CID_154699574 | CID_154699574 | |
| 0.021 | 0.065 | 0.048 | HMG CoA reductase inhibitor | 0.048 0.008 CID_154699899 | CID_154699899 | |
| 0.04 | 0.084 | 0.074 | Glucosylceramidase inhibitor | 0.074 0.019 CID_154699574 | CID_154699574 | |
| 0.03 | 0.073 | 0.076 | Thromboxane antagonist | 0.076 0.022 CID_154699574 | CID_154699574 | |
| 0.047 | 0.091 | 0.079 | Lipocortins synthesis agonist | 0.067 0.024 CID_154699899 0.079 0.014 CID_154699604 0.076 0.016 CID_154699574 | CID_154699604 | |
| 0.036 | 0.082 | 0.056 | HCV NS3/NS4A protease inhibitor | 0.046 0.041 CID_154699899 0.056 0.024 CID_154699604 0.049 0.034 CID_154699574 | CID_154699604 | |
| 0.025 | 0.074 | 0.074 | Thromboxane A2 antagonist | 0.074 0.019 CID_154699574 | CID_154699574 | |
| 0.015 | 0.065 | 0.035 | Prostaglandin D2 agonist | 0.035 0.016 CID_154699899 | CID_154699899 | |
| 0.097 | 0.147 | 0.118 | Acetylcholine M1 receptor antagonist | 0.118 0.111 CID_154699574 | CID_154699574 | |
| 0.075 | 0.126 | 0.309 | Histone deacetylase class III inhibitor | 0.309 0.005 CID_154699604 | CID_154699604 | |
| 0.035 | 0.095 | 0.049 | Glucose-6-phosphate translocase inhibitor | 0.049 0.04 CID_154699574 | CID_154699574 | |
| 0.034 | 0.095 | 0.053 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.051 0.047 CID_154699899 0.053 0.044 CID_154699574 | CID_154699574 | |
| 0.009 | 0.072 | 0.046 | RNA-directed RNA polymerase stimulant | 0.037 0.017 CID_154699899 0.046 0.014 CID_154699604 0.043 0.015 CID_154699574 | CID_154699604 | |
| 0.057 | 0.125 | 0.114 | Bronchodilator | 0.114 0.049 CID_154699574 | CID_154699574 | |
| 0.01 | 0.08 | 0.032 | Acetylcholine M4 receptor agonist | 0.032 0.02 CID_154699574 | CID_154699574 | |
| 0.082 | 0.155 | 0.124 | Thrombolytic | 0.124 0.106 CID_154699574 | CID_154699574 | |
| 0.014 | 0.097 | 0.026 | Vitamin D receptor antagonist | 0.026 0.009 CID_154699899 | CID_154699899 | |
| 0.018 | 0.102 | 0.036 | Toll-Like receptor 4 agonist | 0.036 0.006 CID_154699899 0.027 0.017 CID_154699574 | CID_154699899 | |
| 0.044 | 0.133 | 0.091 | Secretase beta inhibitor | 0.091 0.024 CID_154699899 0.087 0.028 CID_154699574 | CID_154699899 | |
| 0.008 | 0.099 | 0.025 | Corticosteroid-like | 0.021 0.015 CID_154699899 0.024 0.011 CID_154699604 0.025 0.01 CID_154699574 | CID_154699574 | |
| 0.026 | 0.125 | 0.171 | Selectin antagonist | 0.171 0.015 CID_154699899 0.075 0.039 CID_154699604 0.169 0.015 CID_154699574 | CID_154699899 | |
| 0.034 | 0.152 | 0.433 | Sirtuin 1 inhibitor | 0.433 0.002 CID_154699604 | CID_154699604 | |
| 0.047 | 0.168 | 0.102 | Antineoplastic alkaloid | 0.076 0.07 CID_154699899 0.097 0.05 CID_154699604 0.102 0.046 CID_154699574 | CID_154699574 | |
| 0.022 | 0.147 | 0.052 | Thymidine kinase inhibitor | 0.052 0.017 CID_154699574 | CID_154699574 | |
| 0.016 | 0.143 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.023 CID_154699574 | CID_154699574 | |
| 0.068 | 0.221 | 0.268 | Neurotrophic factor | 0.164 0.048 CID_154699899 0.127 0.084 CID_154699604 0.268 0.01 CID_154699574 | CID_154699574 | |
| 0.011 | 0.166 | 0.046 | Antimetabolite | 0.046 0.034 CID_154699574 | CID_154699574 | |
| 0.147 | 0.306 | 0.355 | Interleukin 2 agonist | 0.303 0.071 CID_154699899 0.309 0.068 CID_154699604 0.355 0.043 CID_154699574 | CID_154699574 | |
| 0.033 | 0.196 | 0.221 | Acetylcholine M3 receptor agonist | 0.212 0.004 CID_154699899 0.179 0.008 CID_154699604 0.221 0.004 CID_154699574 | CID_154699574 | |
| 0.013 | 0.176 | 0.048 | Acetylcholine muscarinic agonist | 0.048 0.045 CID_154699574 | CID_154699574 | |
| 0.039 | 0.204 | 0.131 | Protease inhibitor | 0.131 0.04 CID_154699899 0.112 0.055 CID_154699604 0.11 0.056 CID_154699574 | CID_154699899 | |
| 0.077 | 0.245 | 0.265 | Antimitotic | 0.265 0.055 CID_154699899 0.22 0.073 CID_154699574 | CID_154699899 | |
| 0.009 | 0.178 | 0.056 | Caspase 2 inhibitor | 0.052 0.011 CID_154699899 0.039 0.016 CID_154699604 0.056 0.01 CID_154699574 | CID_154699574 | |
| 0.123 | 0.296 | 0.605 | Immunomodulator | 0.605 0.011 CID_154699899 0.396 0.045 CID_154699604 0.434 0.035 CID_154699574 | CID_154699899 | |
| 0.049 | 0.233 | 0.134 | Adenylate cyclase inhibitor | 0.099 0.085 CID_154699899 0.134 0.057 CID_154699574 | CID_154699574 | |
| 0.117 | 0.32 | 0.276 | Peptidyltransferase inhibitor | 0.262 0.043 CID_154699899 0.219 0.077 CID_154699604 0.276 0.035 CID_154699574 | CID_154699574 | |
| 0.017 | 0.241 | 0.067 | Antibiotic Aminoglycoside-like | 0.065 0.007 CID_154699899 0.059 0.009 CID_154699604 0.067 0.007 CID_154699574 | CID_154699574 | |
| 0.013 | 0.249 | 0.12 | Acetylcholine M2 receptor agonist | 0.11 0.005 CID_154699899 0.075 0.016 CID_154699604 0.12 0.005 CID_154699574 | CID_154699574 | |
| 0.089 | 0.34 | 0.18 | Growth factor agonist | 0.18 0.086 CID_154699574 | CID_154699574 | |
| 0.004 | 0.266 | 0.044 | Epoxide hydrolase 2 inhibitor | 0.044 0.007 CID_154699604 | CID_154699604 | |
| 0.062 | 0.333 | 0.164 | NOS3 expression enhancer | 0.154 0.068 CID_154699899 0.131 0.096 CID_154699604 0.164 0.06 CID_154699574 | CID_154699574 | |
| 0.015 | 0.301 | 0.066 | Protein kinase C eta inhibitor | 0.066 0.031 CID_154699574 | CID_154699574 | |
| 0.007 | 0.303 | 0.044 | Protein 30S ribosomal subunit inhibitor | 0.034 0.011 CID_154699899 0.029 0.013 CID_154699604 0.044 0.009 CID_154699574 | CID_154699574 | |
| 0.045 | 0.374 | 0.124 | T cell inhibitor | 0.108 0.019 CID_154699899 0.086 0.046 CID_154699604 0.124 0.013 CID_154699574 | CID_154699574 | |
| 0.004 | 0.45 | 0.148 | Dopamine D1 agonist | 0.099 0.003 CID_154699899 0.131 0.003 CID_154699604 0.148 0.003 CID_154699574 | CID_154699574 | |
| 0.056 | 0.533 | 0.252 | Toll-Like receptor agonist | 0.215 0.184 CID_154699899 0.252 0.146 CID_154699574 | CID_154699574 | |
| 0.049 | 0.53 | 0.251 | Antiobesity | 0.251 0.156 CID_154699899 | CID_154699899 | |
| 0.054 | 0.551 | 0.232 | Toll-Like receptor 7 agonist | 0.232 0.164 CID_154699574 | CID_154699574 | |
| 0.004 | 0.556 | 0.048 | Opioid kappa receptor agonist | 0.048 0.025 CID_154699604 | CID_154699604 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |